Home

Christopher John Kenney, Chief Medical Officer: Xenon Pharmaceuticals XENE Sell · Filed 23/03/24

Trade details

Type
Insider sale
Amount
$24,507
Shares · price
700 sh · $35.01 a share
Held after
0 sh
Trade date
23/03/24
Filed
23/03/24
Days to filing
0 days

Sold 100.0% of holdings

Share of holding sold
100.0%

Xenon Pharmaceuticals trades, last 26 weeks

What else happened in Xenon Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/02/22~23/04/23

Christopher John Kenney's recent trades

  • Christopher John Kenney

    Planned sale10b5-1 planXenon Pharmaceuticals

    $437.7K

    Filed 08/28

  • Christopher John Kenney

    Sell10b5-1 planXenon Pharmaceuticals

    $77.9K

    Filed 03/13

  • Christopher John Kenney

    Planned sale10b5-1 planXenon Pharmaceuticals

    $77.9K

    Filed 03/13

  • Christopher John Kenney

    Sell10b5-1 planXenon Pharmaceuticals

    $166.6K

    Filed 03/11

  • Christopher John Kenney

    Planned sale10b5-1 planXenon Pharmaceuticals

    $166.6K

    Filed 03/10